<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>MedicsKey | 免疫學 | Activity</title>
	<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/</link>
	<atom:link href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the group, 免疫學.</description>
	<lastBuildDate>Mon, 09 Mar 2026 08:53:57 +0800</lastBuildDate>
	<generator>https://buddypress.org/?v=2.16.1</generator>
	<language>zh-TW</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">6ea28695d948eebba3c88ac22852918c</guid>
				<title>MedicsKey.A started the discussion CTLA-4（細胞毒性T淋巴細胞抗原4, CTLA-4）不包括在嵌合抗原受體T細胞（CAR-T）的組成中。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/ctla-4%ef%bc%88%e7%b4%b0%e8%83%9e%e6%af%92%e6%80%a7t%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e6%8a%97%e5%8e%9f4-ctla-4%ef%bc%89%e4%b8%8d%e5%8c%85%e6%8b%ac%e5%9c%a8%e5%b5%8c%e5%90%88%e6%8a%97%e5%8e%9f/</link>
				<pubDate>Thu, 09 Jan 2025 14:09:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/ctla-4%ef%bc%88%e7%b4%b0%e8%83%9e%e6%af%92%e6%80%a7t%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e6%8a%97%e5%8e%9f4-ctla-4%ef%bc%89%e4%b8%8d%e5%8c%85%e6%8b%ac%e5%9c%a8%e5%b5%8c%e5%90%88%e6%8a%97%e5%8e%9f/">CTLA-4（細胞毒性T淋巴細胞抗原4, CTLA-4）不包括在嵌合抗原受體T細胞（CAR-T）的組成中。</a></p> <div class="bb-content-inr-wrap"><p>11212-28 免疫<br />
28.利用基因工程製備嵌合抗原受體T細胞（chimeric antigen receptor T cells, CAR-T）作為免疫細胞治療方式已經成功用來治療ALL（acute lymphocytic leukemia），在此嵌合分子之組成中不包括下列何者？<br />
A.anti-CD19<br />
B.CTLA-4<br />
C.4-1 BB<br />
D.CD3ζ chain</p>
<p>正確答案: B.CTLA-4</p>
<p>為何正確: 在嵌合抗原受體T細胞（CAR-T）的組成中，通常包括一個能識別腫瘤抗原的單鏈抗體如anti-CD19、一個提供共刺激信號的分子如4-1BB，以及一個信號傳遞元件如CD3ζ&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-764"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/ctla-4%ef%bc%88%e7%b4%b0%e8%83%9e%e6%af%92%e6%80%a7t%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e6%8a%97%e5%8e%9f4-ctla-4%ef%bc%89%e4%b8%8d%e5%8c%85%e6%8b%ac%e5%9c%a8%e5%b5%8c%e5%90%88%e6%8a%97%e5%8e%9f/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">e275a61439208c16ed486d64286b584a</guid>
				<title>MedicsKey.A started the discussion 雷帕黴素(rapamycin)抑制白血球增生(proliferation)。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e9%9b%b7%e5%b8%95%e9%bb%b4%e7%b4%a0rapamycin%e6%8a%91%e5%88%b6%e7%99%bd%e8%a1%80%e7%90%83%e5%a2%9e%e7%94%9fproliferation%e3%80%82/</link>
				<pubDate>Thu, 09 Jan 2025 13:49:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e9%9b%b7%e5%b8%95%e9%bb%b4%e7%b4%a0rapamycin%e6%8a%91%e5%88%b6%e7%99%bd%e8%a1%80%e7%90%83%e5%a2%9e%e7%94%9fproliferation%e3%80%82/">雷帕黴素(rapamycin)抑制白血球增生(proliferation)。</a></p> <div class="bb-content-inr-wrap"><p>11212-27 免疫<br />
27.有關雷帕黴素（rapamycin）之作用，下列何者錯誤？<br />
A.與FK結合蛋白（FK-binding protein）結合<br />
B.促進白血球凋亡（apoptosis）<br />
C.抑制白血球增生（proliferation）<br />
D.降低調節性T細胞（regulatory T cell）數目</p>
<p>正確答案: D.降低調節性T細胞（regulatory T cell）數目</p>
<p>為何正確: 雷帕黴素（rapamycin）主要透過與FK結合蛋白（FKBP）結合，形成複合物後抑制mTOR（mammalian target of&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-763"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e9%9b%b7%e5%b8%95%e9%bb%b4%e7%b4%a0rapamycin%e6%8a%91%e5%88%b6%e7%99%bd%e8%a1%80%e7%90%83%e5%a2%9e%e7%94%9fproliferation%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">13d6b821192866327e100a6cc853ccde</guid>
				<title>MedicsKey.A started the discussion 調節性T細胞（regulatory T cells）在發炎處發揮自我免疫耐受性的作用。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%aa%bf%e7%af%80%e6%80%a7t%e7%b4%b0%e8%83%9e%ef%bc%88regulatory-t-cells%ef%bc%89%e5%9c%a8%e7%99%bc%e7%82%8e%e8%99%95%e7%99%bc%e6%8f%ae%e8%87%aa%e6%88%91%e5%85%8d%e7%96%ab%e8%80%90%e5%8f%97%e6%80%a7/</link>
				<pubDate>Thu, 09 Jan 2025 13:41:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%aa%bf%e7%af%80%e6%80%a7t%e7%b4%b0%e8%83%9e%ef%bc%88regulatory-t-cells%ef%bc%89%e5%9c%a8%e7%99%bc%e7%82%8e%e8%99%95%e7%99%bc%e6%8f%ae%e8%87%aa%e6%88%91%e5%85%8d%e7%96%ab%e8%80%90%e5%8f%97%e6%80%a7/">調節性T細胞（regulatory T cells）在發炎處發揮自我免疫耐受性的作用。</a></p> <div class="bb-content-inr-wrap"><p>11212-26免疫<br />
26.下列何種自我免疫耐受性（self-tolerance）機制的作用位置發生在發炎處？<br />
A.central tolerance<br />
B.antigen segregation<br />
C.negative selection<br />
D.regulatory T cells</p>
<p>正確答案: D.regulatory T cells</p>
<p>為何正確: 調節性T細胞（regulatory T&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-762"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%aa%bf%e7%af%80%e6%80%a7t%e7%b4%b0%e8%83%9e%ef%bc%88regulatory-t-cells%ef%bc%89%e5%9c%a8%e7%99%bc%e7%82%8e%e8%99%95%e7%99%bc%e6%8f%ae%e8%87%aa%e6%88%91%e5%85%8d%e7%96%ab%e8%80%90%e5%8f%97%e6%80%a7/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c35a857cc0941ebe8dbc93713da7e48f</guid>
				<title>MedicsKey.A started the discussion 在HIV感染過程中，毒殺型CD8 T細胞和專一性HIV抗體會產生。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%9c%a8hiv%e6%84%9f%e6%9f%93%e9%81%8e%e7%a8%8b%e4%b8%ad%ef%bc%8c%e6%af%92%e6%ae%ba%e5%9e%8bcd8-t%e7%b4%b0%e8%83%9e%e5%92%8c%e5%b0%88%e4%b8%80%e6%80%a7hiv%e6%8a%97%e9%ab%94%e6%9c%83%e7%94%a2%e7%94%9f/</link>
				<pubDate>Thu, 09 Jan 2025 13:38:30 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%9c%a8hiv%e6%84%9f%e6%9f%93%e9%81%8e%e7%a8%8b%e4%b8%ad%ef%bc%8c%e6%af%92%e6%ae%ba%e5%9e%8bcd8-t%e7%b4%b0%e8%83%9e%e5%92%8c%e5%b0%88%e4%b8%80%e6%80%a7hiv%e6%8a%97%e9%ab%94%e6%9c%83%e7%94%a2%e7%94%9f/">在HIV感染過程中，毒殺型CD8 T細胞和專一性HIV抗體會產生。</a></p> <div class="bb-content-inr-wrap"><p>11212-25 免疫<br />
25.HIV會造成慢性感染而且引起後天免疫不全症（acquired immune deficiency syndrome, AIDS）造成許多人死亡，有關HIV慢性感染的原因，下列何者錯誤？<br />
A.在HIV感染的過程中，重要的效應細胞及分子（effector cell / molecule），如毒殺型CD8 T細胞及對HIV有專一性的抗體都沒有產生<br />
B.HIV在複製的過程中會導致基因的突變，使得原本有效的免疫反應失去作用<br />
C.HIV的病毒因子會抑制第一型MHC（MHC class I）在被感染細胞的表現，以逃脫毒殺型CD8 T（cytotoxic CD8&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-761"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%9c%a8hiv%e6%84%9f%e6%9f%93%e9%81%8e%e7%a8%8b%e4%b8%ad%ef%bc%8c%e6%af%92%e6%ae%ba%e5%9e%8bcd8-t%e7%b4%b0%e8%83%9e%e5%92%8c%e5%b0%88%e4%b8%80%e6%80%a7hiv%e6%8a%97%e9%ab%94%e6%9c%83%e7%94%a2%e7%94%9f/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">e857fc069bbfc04b4176e77767fedc27</guid>
				<title>MedicsKey.A started the discussion 共生菌相（commensal microbiota）可以協助產生維生素K和短鏈脂肪酸。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%b1%e7%94%9f%e8%8f%8c%e7%9b%b8%ef%bc%88commensal-microbiota%ef%bc%89%e5%8f%af%e4%bb%a5%e5%8d%94%e5%8a%a9%e7%94%a2%e7%94%9f%e7%b6%ad%e7%94%9f%e7%b4%a0k%e5%92%8c%e7%9f%ad%e9%8f%88%e8%84%82/</link>
				<pubDate>Thu, 09 Jan 2025 13:31:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%b1%e7%94%9f%e8%8f%8c%e7%9b%b8%ef%bc%88commensal-microbiota%ef%bc%89%e5%8f%af%e4%bb%a5%e5%8d%94%e5%8a%a9%e7%94%a2%e7%94%9f%e7%b6%ad%e7%94%9f%e7%b4%a0k%e5%92%8c%e7%9f%ad%e9%8f%88%e8%84%82/">共生菌相（commensal microbiota）可以協助產生維生素K和短鏈脂肪酸。</a></p> <div class="bb-content-inr-wrap"><p>11212-24 免疫<br />
24.下列有關人體內共生菌相（commensal&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-760"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%b1%e7%94%9f%e8%8f%8c%e7%9b%b8%ef%bc%88commensal-microbiota%ef%bc%89%e5%8f%af%e4%bb%a5%e5%8d%94%e5%8a%a9%e7%94%a2%e7%94%9f%e7%b6%ad%e7%94%9f%e7%b4%a0k%e5%92%8c%e7%9f%ad%e9%8f%88%e8%84%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0839a8f1b4d2ed49c54631fc980dcd20</guid>
				<title>MedicsKey.A started the discussion 蛋白質抗原屬於胸腺依賴性抗原（TD抗原），且B細胞完全活化需要兩個訊號：第一個訊號由B細胞的MHC-peptide和T細胞的TCR結合後傳遞，第二個訊號由B細胞的CD40和T細胞的CD40配體（CD40 ligand）結合後傳遞。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%9b%8b%e7%99%bd%e8%b3%aa%e6%8a%97%e5%8e%9f%e5%b1%ac%e6%96%bc%e8%83%b8%e8%85%ba%e4%be%9d%e8%b3%b4%e6%80%a7%e6%8a%97%e5%8e%9f%ef%bc%88td%e6%8a%97%e5%8e%9f%ef%bc%89%ef%bc%8c%e4%b8%94b%e7%b4%b0/</link>
				<pubDate>Thu, 09 Jan 2025 13:28:32 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%9b%8b%e7%99%bd%e8%b3%aa%e6%8a%97%e5%8e%9f%e5%b1%ac%e6%96%bc%e8%83%b8%e8%85%ba%e4%be%9d%e8%b3%b4%e6%80%a7%e6%8a%97%e5%8e%9f%ef%bc%88td%e6%8a%97%e5%8e%9f%ef%bc%89%ef%bc%8c%e4%b8%94b%e7%b4%b0/">蛋白質抗原屬於胸腺依賴性抗原（TD抗原），且B細胞完全活化需要兩個訊號：第一個訊號由B細胞的MHC-peptide和T細胞的TCR結合後傳遞，第二個訊號由B細胞的CD40和T細胞的CD40配體（CD40 ligand）結合後傳遞。</a></p> <div class="bb-content-inr-wrap"><p>11212-23 免疫<br />
23.胸腺依賴性（thymus-dependent）&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-759"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%9b%8b%e7%99%bd%e8%b3%aa%e6%8a%97%e5%8e%9f%e5%b1%ac%e6%96%bc%e8%83%b8%e8%85%ba%e4%be%9d%e8%b3%b4%e6%80%a7%e6%8a%97%e5%8e%9f%ef%bc%88td%e6%8a%97%e5%8e%9f%ef%bc%89%ef%bc%8c%e4%b8%94b%e7%b4%b0/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5f8e9081a6b303a6badb41da242478e4</guid>
				<title>MedicsKey.A started the discussion 嬰兒容易受到具有莢膜的肺炎球菌感染可能是因為嬰兒體內的B細胞尚未成熟。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%85%92%e5%ae%b9%e6%98%93%e5%8f%97%e5%88%b0%e5%85%b7%e6%9c%89%e8%8e%a2%e8%86%9c%e7%9a%84%e8%82%ba%e7%82%8e%e7%90%83%e8%8f%8c%e6%84%9f%e6%9f%93%e5%8f%af%e8%83%bd%e6%98%af%e5%9b%a0%e7%82%ba-2/</link>
				<pubDate>Thu, 09 Jan 2025 13:22:27 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%85%92%e5%ae%b9%e6%98%93%e5%8f%97%e5%88%b0%e5%85%b7%e6%9c%89%e8%8e%a2%e8%86%9c%e7%9a%84%e8%82%ba%e7%82%8e%e7%90%83%e8%8f%8c%e6%84%9f%e6%9f%93%e5%8f%af%e8%83%bd%e6%98%af%e5%9b%a0%e7%82%ba-2/">嬰兒容易受到具有莢膜的肺炎球菌感染可能是因為嬰兒體內的B細胞尚未成熟。</a></p> <div class="bb-content-inr-wrap"><p>11212-23 免疫<br />
23.胸腺依賴性（thymus-dependent）&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-758"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%85%92%e5%ae%b9%e6%98%93%e5%8f%97%e5%88%b0%e5%85%b7%e6%9c%89%e8%8e%a2%e8%86%9c%e7%9a%84%e8%82%ba%e7%82%8e%e7%90%83%e8%8f%8c%e6%84%9f%e6%9f%93%e5%8f%af%e8%83%bd%e6%98%af%e5%9b%a0%e7%82%ba-2/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4ac52b4c8ce736bc39c451e2d51c1f85</guid>
				<title>MedicsKey.A started the discussion 嬰兒容易受到具有莢膜的肺炎球菌感染可能是因為嬰兒體內的B細胞尚未成熟。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%85%92%e5%ae%b9%e6%98%93%e5%8f%97%e5%88%b0%e5%85%b7%e6%9c%89%e8%8e%a2%e8%86%9c%e7%9a%84%e8%82%ba%e7%82%8e%e7%90%83%e8%8f%8c%e6%84%9f%e6%9f%93%e5%8f%af%e8%83%bd%e6%98%af%e5%9b%a0%e7%82%ba/</link>
				<pubDate>Thu, 09 Jan 2025 13:22:22 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%85%92%e5%ae%b9%e6%98%93%e5%8f%97%e5%88%b0%e5%85%b7%e6%9c%89%e8%8e%a2%e8%86%9c%e7%9a%84%e8%82%ba%e7%82%8e%e7%90%83%e8%8f%8c%e6%84%9f%e6%9f%93%e5%8f%af%e8%83%bd%e6%98%af%e5%9b%a0%e7%82%ba/">嬰兒容易受到具有莢膜的肺炎球菌感染可能是因為嬰兒體內的B細胞尚未成熟。</a></p> <div class="bb-content-inr-wrap"><p>11212-23 免疫<br />
23.胸腺依賴性（thymus-dependent）&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-757"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%85%92%e5%ae%b9%e6%98%93%e5%8f%97%e5%88%b0%e5%85%b7%e6%9c%89%e8%8e%a2%e8%86%9c%e7%9a%84%e8%82%ba%e7%82%8e%e7%90%83%e8%8f%8c%e6%84%9f%e6%9f%93%e5%8f%af%e8%83%bd%e6%98%af%e5%9b%a0%e7%82%ba/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">951036527340ac2333827ff47c6eb71b</guid>
				<title>MedicsKey.A started the discussion 拮抗型IL-4抗體（anti-IL-4 antibody）主要抑制TH2型免疫反應（TH2 response）。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%8b%ae%e6%8a%97%e5%9e%8bil-4%e6%8a%97%e9%ab%94%ef%bc%88anti-il-4-antibody%ef%bc%89%e4%b8%bb%e8%a6%81%e6%8a%91%e5%88%b6th2%e5%9e%8b%e5%85%8d%e7%96%ab%e5%8f%8d%e6%87%89%ef%bc%88th2-response%ef%bc%89/</link>
				<pubDate>Thu, 09 Jan 2025 11:33:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%8b%ae%e6%8a%97%e5%9e%8bil-4%e6%8a%97%e9%ab%94%ef%bc%88anti-il-4-antibody%ef%bc%89%e4%b8%bb%e8%a6%81%e6%8a%91%e5%88%b6th2%e5%9e%8b%e5%85%8d%e7%96%ab%e5%8f%8d%e6%87%89%ef%bc%88th2-response%ef%bc%89/">拮抗型IL-4抗體（anti-IL-4 antibody）主要抑制TH2型免疫反應（TH2 response）。</a></p> <div class="bb-content-inr-wrap"><p>11212-22 免疫<br />
22.在注射利什曼原蟲（Leishmania major）小鼠的實驗中，可藉由注射拮抗型IL-4抗體（anti-IL-4 antibody）而明顯增加感染小鼠存活率，此機轉主要是抑制何種免疫反應？<br />
A.TH1 response<br />
B.TH17 response<br />
C.TH2 response<br />
D.chemotaxis response</p>
<p>正確答案:<br />
C.TH2 response</p>
<p>為何正確:<br />
在利什曼原蟲（Leishmania major）感染的小鼠實驗中，注射拮抗型IL-4抗體（anti-IL-4&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-756"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%8b%ae%e6%8a%97%e5%9e%8bil-4%e6%8a%97%e9%ab%94%ef%bc%88anti-il-4-antibody%ef%bc%89%e4%b8%bb%e8%a6%81%e6%8a%91%e5%88%b6th2%e5%9e%8b%e5%85%8d%e7%96%ab%e5%8f%8d%e6%87%89%ef%bc%88th2-response%ef%bc%89/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">578d9c5f29a08199d75902703aba4855</guid>
				<title>MedicsKey.A started the discussion T細胞發育過程中的正向選擇發生在T細胞受體（TCR）與胸腺上皮細胞表面的MHC-peptide進行適度相互作用時，可引發中等強度的TCR訊號。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e7%99%bc%e8%82%b2%e9%81%8e%e7%a8%8b%e4%b8%ad%e7%9a%84%e6%ad%a3%e5%90%91%e9%81%b8%e6%93%87%e7%99%bc%e7%94%9f%e5%9c%a8t%e7%b4%b0%e8%83%9e%e5%8f%97%e9%ab%94%ef%bc%88tcr%ef%bc%89/</link>
				<pubDate>Thu, 09 Jan 2025 11:29:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e7%99%bc%e8%82%b2%e9%81%8e%e7%a8%8b%e4%b8%ad%e7%9a%84%e6%ad%a3%e5%90%91%e9%81%b8%e6%93%87%e7%99%bc%e7%94%9f%e5%9c%a8t%e7%b4%b0%e8%83%9e%e5%8f%97%e9%ab%94%ef%bc%88tcr%ef%bc%89/">T細胞發育過程中的正向選擇發生在T細胞受體（TCR）與胸腺上皮細胞表面的MHC-peptide進行適度相互作用時，可引發中等強度的TCR訊號。</a></p> <div class="bb-content-inr-wrap"><p>11212-21免疫<br />
21.下列何者是T細胞發育過程“positive selection”的最適當敘述？<br />
A.胸腺上皮細胞表現AIRE，此蛋白可以促進組織特異性抗原（tissue-specific&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-755"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e7%99%bc%e8%82%b2%e9%81%8e%e7%a8%8b%e4%b8%ad%e7%9a%84%e6%ad%a3%e5%90%91%e9%81%b8%e6%93%87%e7%99%bc%e7%94%9f%e5%9c%a8t%e7%b4%b0%e8%83%9e%e5%8f%97%e9%ab%94%ef%bc%88tcr%ef%bc%89/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">9ead5f8c083a44b51e79b59ae26eb741</guid>
				<title>MedicsKey.A started the discussion Invariant chain（不變鏈）與MHC class II分子的抗原呈獻過程有重要關聯。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/invariant-chain%ef%bc%88%e4%b8%8d%e8%ae%8a%e9%8f%88%ef%bc%89%e8%88%87mhc-class-ii%e5%88%86%e5%ad%90%e7%9a%84%e6%8a%97%e5%8e%9f%e5%91%88%e7%8d%bb%e9%81%8e%e7%a8%8b%e6%9c%89%e9%87%8d%e8%a6%81%e9%97%9c/</link>
				<pubDate>Thu, 09 Jan 2025 11:23:22 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/invariant-chain%ef%bc%88%e4%b8%8d%e8%ae%8a%e9%8f%88%ef%bc%89%e8%88%87mhc-class-ii%e5%88%86%e5%ad%90%e7%9a%84%e6%8a%97%e5%8e%9f%e5%91%88%e7%8d%bb%e9%81%8e%e7%a8%8b%e6%9c%89%e9%87%8d%e8%a6%81%e9%97%9c/">Invariant chain（不變鏈）與MHC class II分子的抗原呈獻過程有重要關聯。</a></p> <div class="bb-content-inr-wrap"><p>11212-20 免疫<br />
20.下列何種蛋白與MHC class II分子的抗原呈獻過程有重要關聯？<br />
A.Calnexin<br />
B.Calreticulin<br />
C.Invariant chain<br />
D.Transporters associated with antigen processing（TAPs）</p>
<p>正確答案:<br />
C.Invariant chain</p>
<p>為何正確:<br />
Invariant chain在MHC class II分子的抗原呈獻過程中扮演重要角色。它結合到MHC class II分子的抗原結合槽中，防止內源性抗原在MHC class II分子於內質網中時結合，並幫助MHC class II分子從內質網到達內體中。在內體中，Invariant&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-754"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/invariant-chain%ef%bc%88%e4%b8%8d%e8%ae%8a%e9%8f%88%ef%bc%89%e8%88%87mhc-class-ii%e5%88%86%e5%ad%90%e7%9a%84%e6%8a%97%e5%8e%9f%e5%91%88%e7%8d%bb%e9%81%8e%e7%a8%8b%e6%9c%89%e9%87%8d%e8%a6%81%e9%97%9c/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c2f3332b881b82d056f5a7c226f3f46e</guid>
				<title>MedicsKey.A started the discussion 發炎所伴隨的紅、腫、熱、痛主要是由宿主的免疫反應引起的，而非病原菌本身直接造成。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%99%bc%e7%82%8e%e6%89%80%e4%bc%b4%e9%9a%a8%e7%9a%84%e7%b4%85%e3%80%81%e8%85%ab%e3%80%81%e7%86%b1%e3%80%81%e7%97%9b%e4%b8%bb%e8%a6%81%e6%98%af%e7%94%b1%e5%ae%bf%e4%b8%bb%e7%9a%84%e5%85%8d%e7%96%ab/</link>
				<pubDate>Thu, 09 Jan 2025 10:59:33 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%99%bc%e7%82%8e%e6%89%80%e4%bc%b4%e9%9a%a8%e7%9a%84%e7%b4%85%e3%80%81%e8%85%ab%e3%80%81%e7%86%b1%e3%80%81%e7%97%9b%e4%b8%bb%e8%a6%81%e6%98%af%e7%94%b1%e5%ae%bf%e4%b8%bb%e7%9a%84%e5%85%8d%e7%96%ab/">發炎所伴隨的紅、腫、熱、痛主要是由宿主的免疫反應引起的，而非病原菌本身直接造成。</a></p> <div class="bb-content-inr-wrap"><p>11212-19 免疫<br />
19.發炎通常是在局部感染或受傷初期所產生的免疫反應，有關發炎的敘述下列何者錯誤？<br />
A.產生發炎的目的是藉由免疫效應分子（immune effector molecule）的增加去攻擊病原菌並促進傷口的癒合<br />
B.發炎所伴隨的紅、腫、熱、痛是由病原菌在複製過程中所釋放的毒力因子（virulence&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-753"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%99%bc%e7%82%8e%e6%89%80%e4%bc%b4%e9%9a%a8%e7%9a%84%e7%b4%85%e3%80%81%e8%85%ab%e3%80%81%e7%86%b1%e3%80%81%e7%97%9b%e4%b8%bb%e8%a6%81%e6%98%af%e7%94%b1%e5%ae%bf%e4%b8%bb%e7%9a%84%e5%85%8d%e7%96%ab/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">8e1746ab3d516f74f28046f8e3d7401d</guid>
				<title>MedicsKey.A started the discussion 樹突細胞（dendritic cell）可以由骨髓系（myeloid lineage）及淋巴系（lymphoid lineage）前驅細胞產生。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%ef%bc%88dendritic-cell%ef%bc%89%e5%8f%af%e4%bb%a5%e7%94%b1%e9%aa%a8%e9%ab%93%e7%b3%bb%ef%bc%88myeloid-lineage%ef%bc%89%e5%8f%8a%e6%b7%8b%e5%b7%b4%e7%b3%bb%ef%bc%88/</link>
				<pubDate>Thu, 09 Jan 2025 10:49:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%ef%bc%88dendritic-cell%ef%bc%89%e5%8f%af%e4%bb%a5%e7%94%b1%e9%aa%a8%e9%ab%93%e7%b3%bb%ef%bc%88myeloid-lineage%ef%bc%89%e5%8f%8a%e6%b7%8b%e5%b7%b4%e7%b3%bb%ef%bc%88/">樹突細胞（dendritic cell）可以由骨髓系（myeloid lineage）及淋巴系（lymphoid lineage）前驅細胞產生。</a></p> <div class="bb-content-inr-wrap"><p>11212-18 免疫<br />
18.大部分的免疫細胞都是由骨髓中的造血幹細胞發育而來，這些免疫細胞又可以依據它們的發育源頭進一步分成骨髓系（myeloid lineage）或淋巴系（lymphoid lineage），下列那一種細胞可以由骨髓系及淋巴系前驅細胞產生？<br />
A.樹突細胞（dendritic cell）<br />
B.先天淋巴細胞（innate lymphoid cell, ILC）<br />
C.紅血球（red blood cell）<br />
D.巨噬細胞（macrophage）</p>
<p>正確答案: A.樹突細胞（dendritic cell）</p>
<p>為何正確: 樹突細胞（dendritic cells）是一種具有獨特功能的免疫細胞，能夠由骨髓系（myeloid&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-752"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%ef%bc%88dendritic-cell%ef%bc%89%e5%8f%af%e4%bb%a5%e7%94%b1%e9%aa%a8%e9%ab%93%e7%b3%bb%ef%bc%88myeloid-lineage%ef%bc%89%e5%8f%8a%e6%b7%8b%e5%b7%b4%e7%b3%bb%ef%bc%88/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c7fe7ba391b3b3368e40342d8a6823c8</guid>
				<title>MedicsKey.A started the discussion CTLA-4蛋白質是結合樹突細胞上的CD80/CD86。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/ctla-4%e8%9b%8b%e7%99%bd%e8%b3%aa%e6%98%af%e7%b5%90%e5%90%88%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%e4%b8%8a%e7%9a%84cd80-cd86%e3%80%82/</link>
				<pubDate>Sat, 04 Jan 2025 05:55:47 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/ctla-4%e8%9b%8b%e7%99%bd%e8%b3%aa%e6%98%af%e7%b5%90%e5%90%88%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%e4%b8%8a%e7%9a%84cd80-cd86%e3%80%82/">CTLA-4蛋白質是結合樹突細胞上的CD80/CD86。</a></p> <div class="bb-content-inr-wrap"><p>11222-28 免疫<br />
28.下列關於anti-CTLA-4應用於腫瘤免疫療法之原理，何者正確？<br />
A.CTLA-4蛋白質是結合樹突細胞（dendritic cell）之主要組織相容複合體（major histocompatibility complex, MHC）<br />
B.CTLA-4蛋白質是結合樹突細胞（dendritic cell）上的PD-1<br />
C.CTLA-4蛋白質是結合樹突細胞（dendritic cell）上的CD80/CD86<br />
D.CTLA-4蛋白質是結合樹突細胞（dendritic cell）上的CD11b</p>
<p>正確答案: C. CTLA-4蛋白質是結合樹突細胞（dendritic cell）上的CD80/CD86</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-566"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/ctla-4%e8%9b%8b%e7%99%bd%e8%b3%aa%e6%98%af%e7%b5%90%e5%90%88%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%e4%b8%8a%e7%9a%84cd80-cd86%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d183e5e82f9274a818d12908af193532</guid>
				<title>MedicsKey.A started the discussion 慢性排斥反應（chronic rejection）主要表現為植體小血管內皮細胞損壞、細胞浸潤、血管壁增厚及纖維化，導致供應血流受限和植體缺血。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%85%a2%e6%80%a7%e6%8e%92%e6%96%a5%e5%8f%8d%e6%87%89%ef%bc%88chronic-rejection%ef%bc%89%e4%b8%bb%e8%a6%81%e8%a1%a8%e7%8f%be%e7%82%ba%e6%a4%8d%e9%ab%94%e5%b0%8f%e8%a1%80%e7%ae%a1%e5%85%a7%e7%9a%ae/</link>
				<pubDate>Sat, 04 Jan 2025 05:48:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%85%a2%e6%80%a7%e6%8e%92%e6%96%a5%e5%8f%8d%e6%87%89%ef%bc%88chronic-rejection%ef%bc%89%e4%b8%bb%e8%a6%81%e8%a1%a8%e7%8f%be%e7%82%ba%e6%a4%8d%e9%ab%94%e5%b0%8f%e8%a1%80%e7%ae%a1%e5%85%a7%e7%9a%ae/">慢性排斥反應（chronic rejection）主要表現為植體小血管內皮細胞損壞、細胞浸潤、血管壁增厚及纖維化，導致供應血流受限和植體缺血。</a></p> <div class="bb-content-inr-wrap"><p>11222-27 免疫<br />
27.器官移植後的慢性排斥（chronic rejection）作用，下列何情況最可能出現？<br />
A.活化的異體反應性natural&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-565"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%85%a2%e6%80%a7%e6%8e%92%e6%96%a5%e5%8f%8d%e6%87%89%ef%bc%88chronic-rejection%ef%bc%89%e4%b8%bb%e8%a6%81%e8%a1%a8%e7%8f%be%e7%82%ba%e6%a4%8d%e9%ab%94%e5%b0%8f%e8%a1%80%e7%ae%a1%e5%85%a7%e7%9a%ae/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ad2d419f06eb33762772a42c96dc007a</guid>
				<title>MedicsKey.A started the discussion 紅斑性狼瘡（SLE）病人的免疫致病機轉主要活化Toll-like receptor 9（TLR-9）。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%b4%85%e6%96%91%e6%80%a7%e7%8b%bc%e7%98%a1%ef%bc%88sle%ef%bc%89%e7%97%85%e4%ba%ba%e7%9a%84%e5%85%8d%e7%96%ab%e8%87%b4%e7%97%85%e6%a9%9f%e8%bd%89%e4%b8%bb%e8%a6%81%e6%b4%bb%e5%8c%96toll-like-recepto/</link>
				<pubDate>Sat, 04 Jan 2025 05:40:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%b4%85%e6%96%91%e6%80%a7%e7%8b%bc%e7%98%a1%ef%bc%88sle%ef%bc%89%e7%97%85%e4%ba%ba%e7%9a%84%e5%85%8d%e7%96%ab%e8%87%b4%e7%97%85%e6%a9%9f%e8%bd%89%e4%b8%bb%e8%a6%81%e6%b4%bb%e5%8c%96toll-like-recepto/">紅斑性狼瘡（SLE）病人的免疫致病機轉主要活化Toll-like receptor 9（TLR-9）。</a></p> <div class="bb-content-inr-wrap"><p>11222-26 免疫<br />
26.紅斑性狼瘡（SLE）病人因細胞核裂解產生對抗dsDNA自體抗體（anti-dsDNA Ab）所導致的免疫致病機轉主要活化何種Toll-like receptor（TLR）？<br />
A.TLR-1<br />
B.TLR-4<br />
C.TLR-7<br />
D.TLR-9</p>
<p>正確答案: D.TLR-9</p>
<p>為何正確: 紅斑性狼瘡（SLE）患者的免疫致病機轉中，對抗雙股DNA的自體抗體（anti-dsDNA Ab）主要活化Toll-like receptor 9（TLR-9）。TLR-9能夠識別細菌和病毒的無甲基化CpG&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-564"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%b4%85%e6%96%91%e6%80%a7%e7%8b%bc%e7%98%a1%ef%bc%88sle%ef%bc%89%e7%97%85%e4%ba%ba%e7%9a%84%e5%85%8d%e7%96%ab%e8%87%b4%e7%97%85%e6%a9%9f%e8%bd%89%e4%b8%bb%e8%a6%81%e6%b4%bb%e5%8c%96toll-like-recepto/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c27be2e3411b767cb36232caa7f83570</guid>
				<title>MedicsKey.A started the discussion 嬰幼兒成長於乾淨的環境中可能增加第一型過敏反應(Immediate hypersensitivity reaction)的風險，與衛生假說相關。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%b9%bc%e5%85%92%e6%88%90%e9%95%b7%e6%96%bc%e4%b9%be%e6%b7%a8%e7%9a%84%e7%92%b0%e5%a2%83%e4%b8%ad%e5%8f%af%e8%83%bd%e5%a2%9e%e5%8a%a0%e7%ac%ac%e4%b8%80%e5%9e%8b%e9%81%8e%e6%95%8f%e5%8f%8d/</link>
				<pubDate>Sat, 04 Jan 2025 05:34:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%b9%bc%e5%85%92%e6%88%90%e9%95%b7%e6%96%bc%e4%b9%be%e6%b7%a8%e7%9a%84%e7%92%b0%e5%a2%83%e4%b8%ad%e5%8f%af%e8%83%bd%e5%a2%9e%e5%8a%a0%e7%ac%ac%e4%b8%80%e5%9e%8b%e9%81%8e%e6%95%8f%e5%8f%8d/">嬰幼兒成長於乾淨的環境中可能增加第一型過敏反應(Immediate hypersensitivity reaction)的風險，與衛生假說相關。</a></p> <div class="bb-content-inr-wrap"><p>11222-25 免疫<br />
25.下列何種情況與第一型過敏反應疾病的發生最有相關？<br />
A.嬰幼兒時期成長於很乾淨的家中<br />
B.2歲前常發生細菌性感染症<br />
C.有麻疹病毒（measles）或A型肝炎病毒感染史<br />
D.病人體內常具有針對某種蛋白質有特異性之高濃度IgG2a</p>
<p>正確答案: A.嬰幼兒時期成長於很乾淨的家中</p>
<p>為何正確: 第一型過敏反應（Type I hypersensitivity）通常與過度清潔的環境有關，這種環境在嬰幼兒期間可能會限制免疫系統的正常發育，從而導致日後過敏的風險增加。衛生假說（Hygiene&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-563"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%ac%b0%e5%b9%bc%e5%85%92%e6%88%90%e9%95%b7%e6%96%bc%e4%b9%be%e6%b7%a8%e7%9a%84%e7%92%b0%e5%a2%83%e4%b8%ad%e5%8f%af%e8%83%bd%e5%a2%9e%e5%8a%a0%e7%ac%ac%e4%b8%80%e5%9e%8b%e9%81%8e%e6%95%8f%e5%8f%8d/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6acf87b1855c54728b5dc100a308c389</guid>
				<title>MedicsKey.A started the discussion oral tolerance可能與分泌TGF-β的T輔助細胞(T helper cells)有關。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/oral-tolerance%e5%8f%af%e8%83%bd%e8%88%87%e5%88%86%e6%b3%8ctgf-%ce%b2%e7%9a%84t%e8%bc%94%e5%8a%a9%e7%b4%b0%e8%83%9et-helper-cells%e6%9c%89%e9%97%9c%e3%80%82/</link>
				<pubDate>Sat, 04 Jan 2025 05:33:30 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/oral-tolerance%e5%8f%af%e8%83%bd%e8%88%87%e5%88%86%e6%b3%8ctgf-%ce%b2%e7%9a%84t%e8%bc%94%e5%8a%a9%e7%b4%b0%e8%83%9et-helper-cells%e6%9c%89%e9%97%9c%e3%80%82/">oral tolerance可能與分泌TGF-β的T輔助細胞(T helper cells)有關。</a></p> <div class="bb-content-inr-wrap"><p>11222-24 免疫<br />
24.下列有關oral tolerance的敘述何者正確？<br />
A.食物經過消化成為小分子，所以不易刺激免疫反應的發生<br />
B.食物經過消化的小分子胜肽，會表現在胸腺而將相關的T細胞去除<br />
C.所有的食物都會引發oral tolerance<br />
D.可能與分泌TGF-β的T輔助細胞有關</p>
<p>正確答案: D.可能與分泌TGF-β的T輔助細胞有關</p>
<p>為何正確: Oral tolerance（口服耐受性）是一種免疫系統現象，表現為對於口服進入體內的抗原不產生免疫反應。調節性T細胞（regulatory T cells,&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-562"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/oral-tolerance%e5%8f%af%e8%83%bd%e8%88%87%e5%88%86%e6%b3%8ctgf-%ce%b2%e7%9a%84t%e8%bc%94%e5%8a%a9%e7%b4%b0%e8%83%9et-helper-cells%e6%9c%89%e9%97%9c%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">06eb883a51fb2d9c49958d1ff9be87e5</guid>
				<title>MedicsKey.A started the discussion 抗體的Fab部分負責中和（neutralization）作用，而非Fc部分。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%8a%97%e9%ab%94%e7%9a%84fab%e9%83%a8%e5%88%86%e8%b2%a0%e8%b2%ac%e4%b8%ad%e5%92%8c%ef%bc%88neutralization%ef%bc%89%e4%bd%9c%e7%94%a8%ef%bc%8c%e8%80%8c%e9%9d%9efc%e9%83%a8%e5%88%86%e3%80%82/</link>
				<pubDate>Sat, 04 Jan 2025 05:16:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%8a%97%e9%ab%94%e7%9a%84fab%e9%83%a8%e5%88%86%e8%b2%a0%e8%b2%ac%e4%b8%ad%e5%92%8c%ef%bc%88neutralization%ef%bc%89%e4%bd%9c%e7%94%a8%ef%bc%8c%e8%80%8c%e9%9d%9efc%e9%83%a8%e5%88%86%e3%80%82/">抗體的Fab部分負責中和（neutralization）作用，而非Fc部分。</a></p> <div class="bb-content-inr-wrap"><p>11222-23 免疫<br />
23.下列何者不是抗體分子Fc部分的功能？<br />
A.活化補體<br />
B.中和（neutralization）作用<br />
C.調理（opsonization）作用<br />
D.促進mast cell 釋放顆粒內物質（degranulation）</p>
<p>正確答案: B.中和（neutralization）作用</p>
<p>為何正確: 抗體的Fc部分並不參與中和作用。中和作用主要是透過抗體的Fab部分直接結合並阻止病原體或毒素與宿主細胞膜的相互作用。Fc部分的功能包括活化補體、調理作用及促進肥大細胞（mast cell）釋放顆粒內物質等。</p>
<p>選項: A<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-561"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%8a%97%e9%ab%94%e7%9a%84fab%e9%83%a8%e5%88%86%e8%b2%a0%e8%b2%ac%e4%b8%ad%e5%92%8c%ef%bc%88neutralization%ef%bc%89%e4%bd%9c%e7%94%a8%ef%bc%8c%e8%80%8c%e9%9d%9efc%e9%83%a8%e5%88%86%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a13405579fcf0c2a11313d397a216afe</guid>
				<title>MedicsKey.A started the discussion B細胞抗原接受器（BCR）在B細胞膜上表現，具有兩個抗原結合位點，可以作為抗體分泌，T細胞抗原接受器（TCR）只有一個抗原結合位點且只表現在細胞膜上。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/b%e7%b4%b0%e8%83%9e%e6%8a%97%e5%8e%9f%e6%8e%a5%e5%8f%97%e5%99%a8%ef%bc%88bcr%ef%bc%89%e5%9c%a8b%e7%b4%b0%e8%83%9e%e8%86%9c%e4%b8%8a%e8%a1%a8%e7%8f%be%ef%bc%8c%e5%85%b7%e6%9c%89%e5%85%a9%e5%80%8b/</link>
				<pubDate>Sat, 04 Jan 2025 05:11:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/b%e7%b4%b0%e8%83%9e%e6%8a%97%e5%8e%9f%e6%8e%a5%e5%8f%97%e5%99%a8%ef%bc%88bcr%ef%bc%89%e5%9c%a8b%e7%b4%b0%e8%83%9e%e8%86%9c%e4%b8%8a%e8%a1%a8%e7%8f%be%ef%bc%8c%e5%85%b7%e6%9c%89%e5%85%a9%e5%80%8b/">B細胞抗原接受器（BCR）在B細胞膜上表現，具有兩個抗原結合位點，可以作為抗體分泌，T細胞抗原接受器（TCR）只有一個抗原結合位點且只表現在細胞膜上。</a></p> <div class="bb-content-inr-wrap"><p>11222-21 免疫<br />
21.T細胞和B細胞的抗原接受器（antigen receptor）是兩種適應性免疫細胞用來辨識抗原的重要工具，有關這兩種細胞抗原接受器的敘述何者錯誤？<br />
A.T細胞抗原接受器（TCR）由α和β鏈構成，而B細胞抗原接受器（BCR）由兩組重鏈（heavy chain）和輕鏈（light chain）構成。兩種抗原接受器都具有變異區（variable region）及固定區（constant&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-560"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/b%e7%b4%b0%e8%83%9e%e6%8a%97%e5%8e%9f%e6%8e%a5%e5%8f%97%e5%99%a8%ef%bc%88bcr%ef%bc%89%e5%9c%a8b%e7%b4%b0%e8%83%9e%e8%86%9c%e4%b8%8a%e8%a1%a8%e7%8f%be%ef%bc%8c%e5%85%b7%e6%9c%89%e5%85%a9%e5%80%8b/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4c430942fa3851f6ebc20709a6c4e60f</guid>
				<title>MedicsKey.A started the discussion T細胞的TCR抗原結合位置中，CDR3（第三互補決定區域, Complementary Determining Region 3）具最大變異度。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e7%9a%84tcr%e6%8a%97%e5%8e%9f%e7%b5%90%e5%90%88%e4%bd%8d%e7%bd%ae%e4%b8%ad%ef%bc%8ccdr3%ef%bc%88%e7%ac%ac%e4%b8%89%e4%ba%92%e8%a3%9c%e6%b1%ba%e5%ae%9a%e5%8d%80%e5%9f%9f-complement/</link>
				<pubDate>Sat, 04 Jan 2025 04:50:31 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e7%9a%84tcr%e6%8a%97%e5%8e%9f%e7%b5%90%e5%90%88%e4%bd%8d%e7%bd%ae%e4%b8%ad%ef%bc%8ccdr3%ef%bc%88%e7%ac%ac%e4%b8%89%e4%ba%92%e8%a3%9c%e6%b1%ba%e5%ae%9a%e5%8d%80%e5%9f%9f-complement/">T細胞的TCR抗原結合位置中，CDR3（第三互補決定區域, Complementary Determining Region 3）具最大變異度。</a></p> <div class="bb-content-inr-wrap"><p>11222-20 免疫<br />
20.關於T細胞的TCR抗原結合位置（complementary determining region, CDR）具最大變異度主要為何者？<br />
A.CDR1<br />
B.CDR2<br />
C.CDR3<br />
D.CDR4</p>
<p>正確答案: C.CDR3</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-559"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e7%9a%84tcr%e6%8a%97%e5%8e%9f%e7%b5%90%e5%90%88%e4%bd%8d%e7%bd%ae%e4%b8%ad%ef%bc%8ccdr3%ef%bc%88%e7%ac%ac%e4%b8%89%e4%ba%92%e8%a3%9c%e6%b1%ba%e5%ae%9a%e5%8d%80%e5%9f%9f-complement/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7646e8f6eb62784bd93b89d77eb8860e</guid>
				<title>MedicsKey.A started the discussion 人類乳突病毒(HPV)相關的子宮頸癌(cervical cancer)可以通過注射疫苗進行預防。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81%e7%97%85%e6%af%92hpv%e7%9b%b8%e9%97%9c%e7%9a%84%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8ccervical-cancer%e5%8f%af%e4%bb%a5%e9%80%9a%e9%81%8e%e6%b3%a8%e5%b0%84/</link>
				<pubDate>Mon, 09 Dec 2024 04:00:26 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81%e7%97%85%e6%af%92hpv%e7%9b%b8%e9%97%9c%e7%9a%84%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8ccervical-cancer%e5%8f%af%e4%bb%a5%e9%80%9a%e9%81%8e%e6%b3%a8%e5%b0%84/">人類乳突病毒(HPV)相關的子宮頸癌(cervical cancer)可以通過注射疫苗進行預防。</a></p> <div class="bb-content-inr-wrap"><p>11312-28 免疫<br />
28.下列何種腫瘤目前可以注射疫苗來預防？<br />
A.non-Hodgkin&#8217;s lymphoma<br />
B.breast cancer with overexpression the receptor of HER-2/neu<br />
C.metastatic melanoma<br />
D.HPV-16 related cervical cancer</p>
<p>正確答案: D.HPV-16 related cervical cancer</p>
<p>為何正確: 人乳頭瘤病毒(HPV, Human Papillomavirus)疫苗可以預防與HPV-16型相關的子宮頸癌(cervical&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-369"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81%e7%97%85%e6%af%92hpv%e7%9b%b8%e9%97%9c%e7%9a%84%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8ccervical-cancer%e5%8f%af%e4%bb%a5%e9%80%9a%e9%81%8e%e6%b3%a8%e5%b0%84/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">73d9c5df6261ffc4abcd98ffabae6b1c</guid>
				<title>MedicsKey.A started the discussion 使用單細胞轉錄體定序（single cell transcriptome sequence）並不是最常用來鑑定腫瘤相關抗原（TAA）的方法。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e4%bd%bf%e7%94%a8%e5%96%ae%e7%b4%b0%e8%83%9e%e8%bd%89%e9%8c%84%e9%ab%94%e5%ae%9a%e5%ba%8f%ef%bc%88single-cell-transcriptome-sequence%ef%bc%89%e4%b8%a6%e4%b8%8d%e6%98%af%e6%9c%80%e5%b8%b8%e7%94%a8/</link>
				<pubDate>Mon, 09 Dec 2024 03:47:15 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e4%bd%bf%e7%94%a8%e5%96%ae%e7%b4%b0%e8%83%9e%e8%bd%89%e9%8c%84%e9%ab%94%e5%ae%9a%e5%ba%8f%ef%bc%88single-cell-transcriptome-sequence%ef%bc%89%e4%b8%a6%e4%b8%8d%e6%98%af%e6%9c%80%e5%b8%b8%e7%94%a8/">使用單細胞轉錄體定序（single cell transcriptome sequence）並不是最常用來鑑定腫瘤相關抗原（TAA）的方法。</a></p> <div class="bb-content-inr-wrap"><p>11312-27 免疫<br />
27.腫瘤抗原根據其特徵可以分為腫瘤相關抗原（tumor associated antigen, TAA）與腫瘤特異性抗原（tumor specific antigen, TSA），下列關於腫瘤抗原的描述，何者最不適當？<br />
A.TAA 這類抗原在正常組織與癌細胞中都可能表現，但在癌細胞中的表現量通常比正常組織要高<br />
B.TSA 因為是基因突變、基因重組或病毒感染所產生的抗原，使用全外顯子定序（whole exome sequence,&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-368"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e4%bd%bf%e7%94%a8%e5%96%ae%e7%b4%b0%e8%83%9e%e8%bd%89%e9%8c%84%e9%ab%94%e5%ae%9a%e5%ba%8f%ef%bc%88single-cell-transcriptome-sequence%ef%bc%89%e4%b8%a6%e4%b8%8d%e6%98%af%e6%9c%80%e5%b8%b8%e7%94%a8/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7df8089abf800468e15ce5862515ded3</guid>
				<title>MedicsKey.A started the discussion IL-10基因剔除小鼠最可能引發發炎性腸道疾病（inflammatory bowel disease），因為IL-10是一種抗炎性細胞因子，調節免疫反應和維持腸道免疫平衡。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/il-10%e5%9f%ba%e5%9b%a0%e5%89%94%e9%99%a4%e5%b0%8f%e9%bc%a0%e6%9c%80%e5%8f%af%e8%83%bd%e5%bc%95%e7%99%bc%e7%99%bc%e7%82%8e%e6%80%a7%e8%85%b8%e9%81%93%e7%96%be%e7%97%85%ef%bc%88inflammatory-bowel-disea/</link>
				<pubDate>Mon, 09 Dec 2024 03:43:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/il-10%e5%9f%ba%e5%9b%a0%e5%89%94%e9%99%a4%e5%b0%8f%e9%bc%a0%e6%9c%80%e5%8f%af%e8%83%bd%e5%bc%95%e7%99%bc%e7%99%bc%e7%82%8e%e6%80%a7%e8%85%b8%e9%81%93%e7%96%be%e7%97%85%ef%bc%88inflammatory-bowel-disea/">IL-10基因剔除小鼠最可能引發發炎性腸道疾病（inflammatory bowel disease），因為IL-10是一種抗炎性細胞因子，調節免疫反應和維持腸道免疫平衡。</a></p> <div class="bb-content-inr-wrap"><p>11312-26 免疫<br />
26.IL-10 基因剔除小鼠（gene knockout mice）最可能引發下列何種自體免疫疾病？<br />
A.發炎性腸道疾病（inflammatory bowel disease）<br />
B.類紅斑性狼瘡（lupus-like syndrome）<br />
C.淋巴細胞增生性疾病（lymphoproliferative disease）<br />
D.類風濕性關節炎（rheumatoid arthritis）</p>
<p>正確答案: A.發炎性腸道疾病（inflammatory bowel disease）</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-367"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/il-10%e5%9f%ba%e5%9b%a0%e5%89%94%e9%99%a4%e5%b0%8f%e9%bc%a0%e6%9c%80%e5%8f%af%e8%83%bd%e5%bc%95%e7%99%bc%e7%99%bc%e7%82%8e%e6%80%a7%e8%85%b8%e9%81%93%e7%96%be%e7%97%85%ef%bc%88inflammatory-bowel-disea/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d1c9877ef8ac0dd86c3012a088224b9b</guid>
				<title>MedicsKey.A started the discussion 過敏性鼻結膜炎（allergic rhinoconjunctivitis）是由IgE介導的第一型過敏反應疾病。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e9%81%8e%e6%95%8f%e6%80%a7%e9%bc%bb%e7%b5%90%e8%86%9c%e7%82%8e%ef%bc%88allergic-rhinoconjunctivitis%ef%bc%89%e6%98%af%e7%94%b1ige%e4%bb%8b%e5%b0%8e%e7%9a%84%e7%ac%ac%e4%b8%80%e5%9e%8b%e9%81%8e/</link>
				<pubDate>Mon, 09 Dec 2024 03:38:14 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e9%81%8e%e6%95%8f%e6%80%a7%e9%bc%bb%e7%b5%90%e8%86%9c%e7%82%8e%ef%bc%88allergic-rhinoconjunctivitis%ef%bc%89%e6%98%af%e7%94%b1ige%e4%bb%8b%e5%b0%8e%e7%9a%84%e7%ac%ac%e4%b8%80%e5%9e%8b%e9%81%8e/">過敏性鼻結膜炎（allergic rhinoconjunctivitis）是由IgE介導的第一型過敏反應疾病。</a></p> <div class="bb-content-inr-wrap"><p>11312-25 免疫<br />
25.下列何者屬於IgE介導的第一型過敏反應疾病？<br />
A.麩質病（celiac disease）<br />
B.血清病（serum sickness）<br />
C.過敏性鼻結膜炎（allergic rhinoconjunctivitis）<br />
D.過敏性接觸性皮膚炎（allergic contact dermatitis）</p>
<p>正確答案: C. 過敏性鼻結膜炎（allergic rhinoconjunctivitis）</p>
<p>為何正確: 過敏性鼻結膜炎（allergic&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-366"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e9%81%8e%e6%95%8f%e6%80%a7%e9%bc%bb%e7%b5%90%e8%86%9c%e7%82%8e%ef%bc%88allergic-rhinoconjunctivitis%ef%bc%89%e6%98%af%e7%94%b1ige%e4%bb%8b%e5%b0%8e%e7%9a%84%e7%ac%ac%e4%b8%80%e5%9e%8b%e9%81%8e/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7b6818072ae2656e1fd75c099282cd2f</guid>
				<title>MedicsKey.A started the discussion Wiskott-Aldrich綜合症（Wiskott-Aldrich syndrome）與WAS基因突變有關。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/wiskott-aldrich%e7%b6%9c%e5%90%88%e7%97%87%ef%bc%88wiskott-aldrich-syndrome%ef%bc%89%e8%88%87was%e5%9f%ba%e5%9b%a0%e7%aa%81%e8%ae%8a%e6%9c%89%e9%97%9c%e3%80%82/</link>
				<pubDate>Mon, 09 Dec 2024 03:34:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/wiskott-aldrich%e7%b6%9c%e5%90%88%e7%97%87%ef%bc%88wiskott-aldrich-syndrome%ef%bc%89%e8%88%87was%e5%9f%ba%e5%9b%a0%e7%aa%81%e8%ae%8a%e6%9c%89%e9%97%9c%e3%80%82/">Wiskott-Aldrich綜合症（Wiskott-Aldrich syndrome）與WAS基因突變有關。</a></p> <div class="bb-content-inr-wrap"><p>11312-24 免疫<br />
24.先天性免疫缺失疾病（primary immunodeficiency diseases）經常是因為與免疫細胞發育或是功能相關的基因缺陷造成。下列疾病與其缺陷基因之配對，何者最不適當？<br />
A.X-linked SCID：IL-2 receptor common gamma chain<br />
B.Wiskott-Aldrich syndrome：NF-κB<br />
C.Bruton&#8217;s X-linked agammaglobulinemia：BTK<br />
D.DiGeorge syndrome：TBX1</p>
<p>正確答案: B.Wiskott-Aldrich syndrome：NF-κB</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-365"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/wiskott-aldrich%e7%b6%9c%e5%90%88%e7%97%87%ef%bc%88wiskott-aldrich-syndrome%ef%bc%89%e8%88%87was%e5%9f%ba%e5%9b%a0%e7%aa%81%e8%ae%8a%e6%9c%89%e9%97%9c%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7f7a3c0801d208dbcf67b1c8523abc59</guid>
				<title>MedicsKey.A started the discussion 腸道上皮細胞最不可能利用前列腺素E2(Prostaglandin E2, PGE2)來幫助清除病原菌。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%85%b8%e9%81%93%e4%b8%8a%e7%9a%ae%e7%b4%b0%e8%83%9e%e6%9c%80%e4%b8%8d%e5%8f%af%e8%83%bd%e5%88%a9%e7%94%a8%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e2prostaglandin-e2-pge2%e4%be%86%e5%b9%ab%e5%8a%a9/</link>
				<pubDate>Sun, 08 Dec 2024 14:09:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%85%b8%e9%81%93%e4%b8%8a%e7%9a%ae%e7%b4%b0%e8%83%9e%e6%9c%80%e4%b8%8d%e5%8f%af%e8%83%bd%e5%88%a9%e7%94%a8%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e2prostaglandin-e2-pge2%e4%be%86%e5%b9%ab%e5%8a%a9/">腸道上皮細胞最不可能利用前列腺素E2(Prostaglandin E2, PGE2)來幫助清除病原菌。</a></p> <div class="bb-content-inr-wrap"><p>11312-23 免疫<br />
23.當病原菌入侵腸道時，腸道上皮細胞最不可能利用下列何種分子來幫助清除病原菌？<br />
A.TLRs<br />
B.NOD1 及 NOD2<br />
C.PGE2<br />
D.MIC-A 及 MIC-B</p>
<p>應選C</p>
<p>正確答案: C. PGE2</p>
<p>為何正確:<br />
PGE2（前列腺素E2, Prostaglandin E2）主要是參與炎症反應及調節免疫反應，但它並不是腸道上皮細胞直接用來清除病原菌的分子。相較之下，TLRs（Toll樣受體, Toll-like receptors）與NOD1及NOD2（核苷酸寡聚化域受體,&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-364"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%85%b8%e9%81%93%e4%b8%8a%e7%9a%ae%e7%b4%b0%e8%83%9e%e6%9c%80%e4%b8%8d%e5%8f%af%e8%83%bd%e5%88%a9%e7%94%a8%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e2prostaglandin-e2-pge2%e4%be%86%e5%b9%ab%e5%8a%a9/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d4e408b9bcac87804d6a88c04035ab2c</guid>
				<title>MedicsKey.A started the discussion 腸道上皮細胞最不可能利用前列腺素E2(PGE2)來直接清除病原菌。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%85%b8%e9%81%93%e4%b8%8a%e7%9a%ae%e7%b4%b0%e8%83%9e%e6%9c%80%e4%b8%8d%e5%8f%af%e8%83%bd%e5%88%a9%e7%94%a8%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e2pge2%e4%be%86%e7%9b%b4%e6%8e%a5%e6%b8%85%e9%99%a4/</link>
				<pubDate>Sun, 08 Dec 2024 14:01:17 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%85%b8%e9%81%93%e4%b8%8a%e7%9a%ae%e7%b4%b0%e8%83%9e%e6%9c%80%e4%b8%8d%e5%8f%af%e8%83%bd%e5%88%a9%e7%94%a8%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e2pge2%e4%be%86%e7%9b%b4%e6%8e%a5%e6%b8%85%e9%99%a4/">腸道上皮細胞最不可能利用前列腺素E2(PGE2)來直接清除病原菌。</a></p> <div class="bb-content-inr-wrap"><p>11312-23 免疫<br />
23.當病原菌入侵腸道時，腸道上皮細胞最不可能利用下列何種分子來幫助清除病原菌？<br />
A.TLRs<br />
B.NOD1 及 NOD2<br />
C.PGE2<br />
D.MIC-A 及 MIC-B</p>
<p>正確答案: D. MIC-A 及 MIC-B</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-363"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%85%b8%e9%81%93%e4%b8%8a%e7%9a%ae%e7%b4%b0%e8%83%9e%e6%9c%80%e4%b8%8d%e5%8f%af%e8%83%bd%e5%88%a9%e7%94%a8%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e2pge2%e4%be%86%e7%9b%b4%e6%8e%a5%e6%b8%85%e9%99%a4/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">838ff3ae997f50aeaf7f3c09b756665f</guid>
				<title>MedicsKey.A started the discussion IgM（免疫球蛋白M, Immunoglobulin M）是B細胞活化後最早分泌出來的抗體。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/igm%ef%bc%88%e5%85%8d%e7%96%ab%e7%90%83%e8%9b%8b%e7%99%bdm-immunoglobulin-m%ef%bc%89%e6%98%afb%e7%b4%b0%e8%83%9e%e6%b4%bb%e5%8c%96%e5%be%8c%e6%9c%80%e6%97%a9%e5%88%86%e6%b3%8c%e5%87%ba%e4%be%86/</link>
				<pubDate>Sun, 08 Dec 2024 05:46:13 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/igm%ef%bc%88%e5%85%8d%e7%96%ab%e7%90%83%e8%9b%8b%e7%99%bdm-immunoglobulin-m%ef%bc%89%e6%98%afb%e7%b4%b0%e8%83%9e%e6%b4%bb%e5%8c%96%e5%be%8c%e6%9c%80%e6%97%a9%e5%88%86%e6%b3%8c%e5%87%ba%e4%be%86/">IgM（免疫球蛋白M, Immunoglobulin M）是B細胞活化後最早分泌出來的抗體。</a></p> <div class="bb-content-inr-wrap"><p>11312-22 免疫<br />
22.有關抗體之敘述，下列何者最適當？<br />
A.IgA 可穿過胎盤，讓胎兒獲得被動免疫力<br />
B.IgE 是活化補體的最主要抗體<br />
C.IgM 是 B細胞活化後最早分泌出來的抗體<br />
D.IgG 是活化mast cells的最主要抗體</p>
<p>正確答案: C.IgM 是 B細胞活化後最早分泌出來的抗體</p>
<p>為何正確: IgM是B細胞（B cell）活化後最早分泌的抗體（antibody）。在初次免疫反應中，IgM是最早被產生的抗體，然後在免疫反應的後期會有類型轉換（class switching）產生其他類型的抗體如IgG。IgM的出現象徵著身體對抗原的初次暴露，因此對於診斷初次感染特別有用。</p>
<p>選項: A<br />
詳解: IgA（免疫球蛋白A, Immunoglobulin&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-362"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/igm%ef%bc%88%e5%85%8d%e7%96%ab%e7%90%83%e8%9b%8b%e7%99%bdm-immunoglobulin-m%ef%bc%89%e6%98%afb%e7%b4%b0%e8%83%9e%e6%b4%bb%e5%8c%96%e5%be%8c%e6%9c%80%e6%97%a9%e5%88%86%e6%b3%8c%e5%87%ba%e4%be%86/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a5e0731d0c5c33cc34b87331bd6032f7</guid>
				<title>MedicsKey.A started the discussion B細胞、樹突細胞（dendritic cells, DC）及巨噬細胞（macrophages）皆會表現MHC class II及B7分子，因此被稱為抗原呈獻細胞（APCs）。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/b%e7%b4%b0%e8%83%9e%e3%80%81%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%ef%bc%88dendritic-cells-dc%ef%bc%89%e5%8f%8a%e5%b7%a8%e5%99%ac%e7%b4%b0%e8%83%9e%ef%bc%88macrophages%ef%bc%89%e7%9a%86%e6%9c%83/</link>
				<pubDate>Sun, 08 Dec 2024 05:41:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/b%e7%b4%b0%e8%83%9e%e3%80%81%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%ef%bc%88dendritic-cells-dc%ef%bc%89%e5%8f%8a%e5%b7%a8%e5%99%ac%e7%b4%b0%e8%83%9e%ef%bc%88macrophages%ef%bc%89%e7%9a%86%e6%9c%83/">B細胞、樹突細胞（dendritic cells, DC）及巨噬細胞（macrophages）皆會表現MHC class II及B7分子，因此被稱為抗原呈獻細胞（APCs）。</a></p> <div class="bb-content-inr-wrap"><p>11312-21 免疫<br />
21.有關B細胞、樹突細胞及巨噬細胞之敘述，下列何者最適當？<br />
A.三者皆會表現MHC class II及B7分子，所以被稱為抗原呈獻細胞<br />
B.三者皆會表現MHC class II，但不表現MHC class I<br />
C.三者皆會活化T細胞，但以B細胞最易活化naïve T細胞<br />
D.三者平常皆維持不成熟狀態在周邊巡邏，遇到抗原後會分化進入成熟狀態，遷移至附近淋巴組織中</p>
<p>正確答案: A.三者皆會表現MHC class II及B7分子，所以被稱為抗原呈獻細胞</p>
<p>為何正確: B細胞、樹突細胞(樹突狀細胞, Dendritic&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-361"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/b%e7%b4%b0%e8%83%9e%e3%80%81%e6%a8%b9%e7%aa%81%e7%b4%b0%e8%83%9e%ef%bc%88dendritic-cells-dc%ef%bc%89%e5%8f%8a%e5%b7%a8%e5%99%ac%e7%b4%b0%e8%83%9e%ef%bc%88macrophages%ef%bc%89%e7%9a%86%e6%9c%83/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">749953e23052e604e11fc8f1228206dd</guid>
				<title>MedicsKey.A started the discussion 克隆擴增(clonal expansion)是指淋巴細胞的抗原受體與抗原結合後，經由活化大量增殖，主要發生在淋巴組織中。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%8b%e9%9a%86%e6%93%b4%e5%a2%9eclonal-expansion%e6%98%af%e6%8c%87%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e7%9a%84%e6%8a%97%e5%8e%9f%e5%8f%97%e9%ab%94%e8%88%87%e6%8a%97%e5%8e%9f%e7%b5%90%e5%90%88/</link>
				<pubDate>Sun, 08 Dec 2024 05:32:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%8b%e9%9a%86%e6%93%b4%e5%a2%9eclonal-expansion%e6%98%af%e6%8c%87%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e7%9a%84%e6%8a%97%e5%8e%9f%e5%8f%97%e9%ab%94%e8%88%87%e6%8a%97%e5%8e%9f%e7%b5%90%e5%90%88/">克隆擴增(clonal expansion)是指淋巴細胞的抗原受體與抗原結合後，經由活化大量增殖，主要發生在淋巴組織中。</a></p> <div class="bb-content-inr-wrap"><p>11312-20 免疫<br />
20.下列有關T細胞或B細胞抗原受體的敘述，何者最不適當？<br />
A.TCR α chain和TCR β chain形成配對，而TCR γ chain和TCR δ chain形成配對<br />
B.氫鍵與凡德瓦力參與受體與抗原的結合過程<br />
C.clonal expansion 是指淋巴細胞於胸腺或骨髓的發育過程中，其細胞表面上的抗原受體與外來抗原結合後，引起細胞大量增殖<br />
D.MHC restriction&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-360"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%8b%e9%9a%86%e6%93%b4%e5%a2%9eclonal-expansion%e6%98%af%e6%8c%87%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e7%9a%84%e6%8a%97%e5%8e%9f%e5%8f%97%e9%ab%94%e8%88%87%e6%8a%97%e5%8e%9f%e7%b5%90%e5%90%88/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7847ca1e58169c3c717fbea5fcac8c48</guid>
				<title>MedicsKey.A started the discussion 第一型干擾素（type I interferon）主要通過調節免疫反應、影響基因表達和抑制病毒複製發揮作用，並不直接參與分解病毒。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%ac%ac%e4%b8%80%e5%9e%8b%e5%b9%b2%e6%93%be%e7%b4%a0%ef%bc%88type-i-interferon%ef%bc%89%e4%b8%bb%e8%a6%81%e9%80%9a%e9%81%8e%e8%aa%bf%e7%af%80%e5%85%8d%e7%96%ab%e5%8f%8d%e6%87%89%e3%80%81%e5%bd%b1/</link>
				<pubDate>Sun, 08 Dec 2024 05:23:46 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%ac%ac%e4%b8%80%e5%9e%8b%e5%b9%b2%e6%93%be%e7%b4%a0%ef%bc%88type-i-interferon%ef%bc%89%e4%b8%bb%e8%a6%81%e9%80%9a%e9%81%8e%e8%aa%bf%e7%af%80%e5%85%8d%e7%96%ab%e5%8f%8d%e6%87%89%e3%80%81%e5%bd%b1/">第一型干擾素（type I interferon）主要通過調節免疫反應、影響基因表達和抑制病毒複製發揮作用，並不直接參與分解病毒。</a></p> <div class="bb-content-inr-wrap"><p>11312-19 免疫<br />
19.關於第一型干擾素（type I interferon），下列敘述何者最不適當？<br />
A.病毒感染有核細胞後，會刺激第一型干擾素的產生<br />
B.第一型干擾素可以直接參與分解病毒<br />
C.第一型干擾素可以活化細胞內基因以破壞病毒mRNA及抑制病毒蛋白的轉譯<br />
D.第一型干擾素可以誘導細胞第一型MHC分子的表達，增加感染的細胞呈獻抗原給CD8毒殺T細胞</p>
<p>正確答案: B.第一型干擾素可以直接參與分解病毒</p>
<p>為何正確: 第一型干擾素（type I&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-359"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%ac%ac%e4%b8%80%e5%9e%8b%e5%b9%b2%e6%93%be%e7%b4%a0%ef%bc%88type-i-interferon%ef%bc%89%e4%b8%bb%e8%a6%81%e9%80%9a%e9%81%8e%e8%aa%bf%e7%af%80%e5%85%8d%e7%96%ab%e5%8f%8d%e6%87%89%e3%80%81%e5%bd%b1/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">515a55f704b3bead2c5c096d3f607b80</guid>
				<title>MedicsKey.A started the discussion 胎心（fetal heart）不是造血作用的場所。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%83%8e%e5%bf%83%ef%bc%88fetal-heart%ef%bc%89%e4%b8%8d%e6%98%af%e9%80%a0%e8%a1%80%e4%bd%9c%e7%94%a8%e7%9a%84%e5%a0%b4%e6%89%80%e3%80%82/</link>
				<pubDate>Sun, 08 Dec 2024 03:36:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%83%8e%e5%bf%83%ef%bc%88fetal-heart%ef%bc%89%e4%b8%8d%e6%98%af%e9%80%a0%e8%a1%80%e4%bd%9c%e7%94%a8%e7%9a%84%e5%a0%b4%e6%89%80%e3%80%82/">胎心（fetal heart）不是造血作用的場所。</a></p> <div class="bb-content-inr-wrap"><p>11312-18 免疫<br />
18.經由造血作用（hematopoiesis）產生免疫細胞的過程，最不可能在動物體內何處發生？<br />
A.yolk sac<br />
B.fetal liver<br />
C.fetal heart<br />
D.bone marrow</p>
<p>正確答案: C. fetal heart</p>
<p>為何正確: 造血作用（hematopoiesis）主要是在卵黃囊（yolk sac）、胎肝（fetal liver）和骨髓（bone marrow）中進行，這些都是已知的造血部位。然而，胎心（fetal heart）並不是造血作用的部位，因此在動物體內最不可能進行造血作用的就是胎心。</p>
<p>選項: A<br />
詳解: 卵黃囊（yolk&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-358"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%83%8e%e5%bf%83%ef%bc%88fetal-heart%ef%bc%89%e4%b8%8d%e6%98%af%e9%80%a0%e8%a1%80%e4%bd%9c%e7%94%a8%e7%9a%84%e5%a0%b4%e6%89%80%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7b7f2ab4994640fe39a61bdd0d075825</guid>
				<title>MedicsKey.A started the discussion 超急性排斥反應(hyperacute rejection)通常在移植手術後數分鐘內發生。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%b6%85%e6%80%a5%e6%80%a7%e6%8e%92%e6%96%a5%e5%8f%8d%e6%87%89hyperacute-rejection%e9%80%9a%e5%b8%b8%e5%9c%a8%e7%a7%bb%e6%a4%8d%e6%89%8b%e8%a1%93%e5%be%8c%e6%95%b8%e5%88%86%e9%90%98%e5%85%a7/</link>
				<pubDate>Sun, 24 Nov 2024 09:15:26 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%b6%85%e6%80%a5%e6%80%a7%e6%8e%92%e6%96%a5%e5%8f%8d%e6%87%89hyperacute-rejection%e9%80%9a%e5%b8%b8%e5%9c%a8%e7%a7%bb%e6%a4%8d%e6%89%8b%e8%a1%93%e5%be%8c%e6%95%b8%e5%88%86%e9%90%98%e5%85%a7/">超急性排斥反應(hyperacute rejection)通常在移植手術後數分鐘內發生。</a></p> <div class="bb-content-inr-wrap"><p>11322-28 免疫<br />
28.超急性排斥反應(hyperacute rejection)通常是在移植手術後多久發生?<br />
A.數分鐘內<br />
B.2~5天<br />
C.7~21天<br />
D.1~3個月</p>
<p>正確答案: A.數分鐘內</p>
<p>為何正確:<br />
超急性排斥反應(hyperacute rejection)是由於受體體內預存的對抗捐贈者抗原的抗體與捐贈者的器官或組織的一致性抗原發生反應，這一過程通常在移植後的數分鐘或數小時內發生。這種反應通常會導致移植物快速失敗。</p>
<p>選項:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-159"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%b6%85%e6%80%a5%e6%80%a7%e6%8e%92%e6%96%a5%e5%8f%8d%e6%87%89hyperacute-rejection%e9%80%9a%e5%b8%b8%e5%9c%a8%e7%a7%bb%e6%a4%8d%e6%89%8b%e8%a1%93%e5%be%8c%e6%95%b8%e5%88%86%e9%90%98%e5%85%a7/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">57586f46a0bcefe21a316bf18a25d03e</guid>
				<title>MedicsKey.A started the discussion 細胞激素激活殺手細胞(cytokine-induced killer, CIK)雖為體外培養的T細胞，但其腫瘤特異性較低。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%b4%b0%e8%83%9e%e6%bf%80%e7%b4%a0%e6%bf%80%e6%b4%bb%e6%ae%ba%e6%89%8b%e7%b4%b0%e8%83%9ecytokine-induced-killer-cik%e9%9b%96%e7%82%ba%e9%ab%94%e5%a4%96%e5%9f%b9%e9%a4%8a%e7%9a%84t%e7%b4%b0/</link>
				<pubDate>Sun, 24 Nov 2024 09:04:15 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%b4%b0%e8%83%9e%e6%bf%80%e7%b4%a0%e6%bf%80%e6%b4%bb%e6%ae%ba%e6%89%8b%e7%b4%b0%e8%83%9ecytokine-induced-killer-cik%e9%9b%96%e7%82%ba%e9%ab%94%e5%a4%96%e5%9f%b9%e9%a4%8a%e7%9a%84t%e7%b4%b0/">細胞激素激活殺手細胞(cytokine-induced killer, CIK)雖為體外培養的T細胞，但其腫瘤特異性較低。</a></p> <div class="bb-content-inr-wrap"><p>11322-27 免疫<br />
27.目前有許多癌症治療是透過給與免疫細胞或激活免疫系統而達成，關於癌症免疫治療，下列敘述何者最不適當?<br />
A.mRNA癌症疫苗需先找到腫瘤的基因突變，根據病人的HLA預測新生抗原(neoantigen)，再根據預測結果合 成mRNA，透過脂質奈米粒包覆mRNA，注射疫苗後激活腫瘤特異性細胞的免疫反應<br />
B.細胞激素激活殺手細胞(cytokine-induced killer, CIK)，是將T細胞在含有多種促發炎細胞激素(pro- inflammatory&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-158"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%b4%b0%e8%83%9e%e6%bf%80%e7%b4%a0%e6%bf%80%e6%b4%bb%e6%ae%ba%e6%89%8b%e7%b4%b0%e8%83%9ecytokine-induced-killer-cik%e9%9b%96%e7%82%ba%e9%ab%94%e5%a4%96%e5%9f%b9%e9%a4%8a%e7%9a%84t%e7%b4%b0/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">982f1fb89fa40d29f10a85fc5f8ac06c</guid>
				<title>MedicsKey.A started the discussion 調節型T細胞(regulatory T cell)主要以細胞毒殺的方式，移除其辨識的自體細胞。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%aa%bf%e7%af%80%e5%9e%8bt%e7%b4%b0%e8%83%9eregulatory-t-cell%e4%b8%bb%e8%a6%81%e4%bb%a5%e7%b4%b0%e8%83%9e%e6%af%92%e6%ae%ba%e7%9a%84%e6%96%b9%e5%bc%8f%ef%bc%8c%e7%a7%bb%e9%99%a4%e5%85%b6%e8%be%a8/</link>
				<pubDate>Sun, 24 Nov 2024 08:54:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%aa%bf%e7%af%80%e5%9e%8bt%e7%b4%b0%e8%83%9eregulatory-t-cell%e4%b8%bb%e8%a6%81%e4%bb%a5%e7%b4%b0%e8%83%9e%e6%af%92%e6%ae%ba%e7%9a%84%e6%96%b9%e5%bc%8f%ef%bc%8c%e7%a7%bb%e9%99%a4%e5%85%b6%e8%be%a8/">調節型T細胞(regulatory T cell)主要以細胞毒殺的方式，移除其辨識的自體細胞。</a></p> <div class="bb-content-inr-wrap"><p>11322-26 免疫<br />
26.自體免疫疾病是由於免疫系統針對自體抗原產生一系列免疫反應而產生的疾病。自體免疫疾病的形成，必須<br />
  突破多重免疫耐受的機制。下列有關自體免疫的敘述，何者最不適當?<br />
A.免疫豁免部位，例如眼、子宮等器官，若遭受創傷導致組織特異抗原得以被周邊免疫細胞偵測時，可能引&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-157"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%aa%bf%e7%af%80%e5%9e%8bt%e7%b4%b0%e8%83%9eregulatory-t-cell%e4%b8%bb%e8%a6%81%e4%bb%a5%e7%b4%b0%e8%83%9e%e6%af%92%e6%ae%ba%e7%9a%84%e6%96%b9%e5%bc%8f%ef%bc%8c%e7%a7%bb%e9%99%a4%e5%85%b6%e8%be%a8/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">e2afa19416d50fcf9c0f2961cd8c7f5b</guid>
				<title>MedicsKey.A started the discussion 免疫性血小板缺乏症（immune thrombocytopenia）主要是由type II過敏反應（hypersensitivity）所導致。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%8d%e7%96%ab%e6%80%a7%e8%a1%80%e5%b0%8f%e6%9d%bf%e7%bc%ba%e4%b9%8f%e7%97%87%ef%bc%88immune-thrombocytopenia%ef%bc%89%e4%b8%bb%e8%a6%81%e6%98%af%e7%94%b1type-ii%e9%81%8e%e6%95%8f%e5%8f%8d/</link>
				<pubDate>Sat, 23 Nov 2024 15:21:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%8d%e7%96%ab%e6%80%a7%e8%a1%80%e5%b0%8f%e6%9d%bf%e7%bc%ba%e4%b9%8f%e7%97%87%ef%bc%88immune-thrombocytopenia%ef%bc%89%e4%b8%bb%e8%a6%81%e6%98%af%e7%94%b1type-ii%e9%81%8e%e6%95%8f%e5%8f%8d/">免疫性血小板缺乏症（immune thrombocytopenia）主要是由type II過敏反應（hypersensitivity）所導致。</a></p> <div class="bb-content-inr-wrap"><p>11322-25 免疫<br />
25.免疫性血小板缺乏症（immune thrombocytopenia）最主要是由下列何種過敏反應（hypersensitivity）所導致？<br />
A.type I過敏反應<br />
B.type II過敏反應<br />
C.type III過敏反應<br />
D.type IV過敏反應</p>
<p>正確答案: B.type II過敏反應</p>
<p>為何正確:<br />
免疫性血小板缺乏症（immune thrombocytopenia）主要涉及抗體與血小板表面抗原的結合，導致血小板被破壞。這是一種典型的第二型過敏反應（type II hypersensitivity），其中，自體抗體針對血小板，導致補體系統或巨噬細胞系統介導的細胞毒性，進而引起血小板減少。</p>
<p>選項:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-156"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e5%85%8d%e7%96%ab%e6%80%a7%e8%a1%80%e5%b0%8f%e6%9d%bf%e7%bc%ba%e4%b9%8f%e7%97%87%ef%bc%88immune-thrombocytopenia%ef%bc%89%e4%b8%bb%e8%a6%81%e6%98%af%e7%94%b1type-ii%e9%81%8e%e6%95%8f%e5%8f%8d/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5bf37e9e9a23a04bdbfffc6be38d2bff</guid>
				<title>MedicsKey.A started the discussion 活性減毒疫苗（例如沙賓小兒麻痺疫苗）最不適合用於先天性免疫不全的病人。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%b4%bb%e6%80%a7%e6%b8%9b%e6%af%92%e7%96%ab%e8%8b%97%ef%bc%88%e4%be%8b%e5%a6%82%e6%b2%99%e8%b3%93%e5%b0%8f%e5%85%92%e9%ba%bb%e7%97%ba%e7%96%ab%e8%8b%97%ef%bc%89%e6%9c%80%e4%b8%8d%e9%81%a9%e5%90%88/</link>
				<pubDate>Sat, 23 Nov 2024 11:03:36 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%b4%bb%e6%80%a7%e6%b8%9b%e6%af%92%e7%96%ab%e8%8b%97%ef%bc%88%e4%be%8b%e5%a6%82%e6%b2%99%e8%b3%93%e5%b0%8f%e5%85%92%e9%ba%bb%e7%97%ba%e7%96%ab%e8%8b%97%ef%bc%89%e6%9c%80%e4%b8%8d%e9%81%a9%e5%90%88/">活性減毒疫苗（例如沙賓小兒麻痺疫苗）最不適合用於先天性免疫不全的病人。</a></p> <div class="bb-content-inr-wrap"><p>11322-24免疫<br />
24.疫苗接種（vaccination）是公共衛生常用以預防傳染病的手段。下列何者最不適合用於先天性免疫不全的病人？<br />
A.B型肝炎（hepatitis B）疫苗<br />
B.沙賓（Sabin）小兒麻痺疫苗<br />
C.白喉、破傷風、百日咳三合一（DPT）疫苗<br />
D.注射型流行性感冒（influenza）疫苗</p>
<p>正確答案:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-155"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e6%b4%bb%e6%80%a7%e6%b8%9b%e6%af%92%e7%96%ab%e8%8b%97%ef%bc%88%e4%be%8b%e5%a6%82%e6%b2%99%e8%b3%93%e5%b0%8f%e5%85%92%e9%ba%bb%e7%97%ba%e7%96%ab%e8%8b%97%ef%bc%89%e6%9c%80%e4%b8%8d%e9%81%a9%e5%90%88/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">55390fe6e0dc93be5fea030586a1903a</guid>
				<title>MedicsKey.A started the discussion 肺炎鏈球菌多醣體疫苗(Polysaccharide Vaccine)以thymus-independent方式活化B細胞。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97polysaccharide-vaccine%e4%bb%a5thymus-independent%e6%96%b9%e5%bc%8f%e6%b4%bb%e5%8c%96b%e7%b4%b0%e8%83%9e/</link>
				<pubDate>Sat, 23 Nov 2024 10:59:45 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97polysaccharide-vaccine%e4%bb%a5thymus-independent%e6%96%b9%e5%bc%8f%e6%b4%bb%e5%8c%96b%e7%b4%b0%e8%83%9e/">肺炎鏈球菌多醣體疫苗(Polysaccharide Vaccine)以thymus-independent方式活化B細胞。</a></p> <div class="bb-content-inr-wrap"><p>11322-23 免疫<br />
23.下列有關肺炎鏈球菌多醣體疫苗之敘述，何者最不適當？<br />
A.是多醣體連結蛋白質形成的疫苗<br />
B.以thymus-independent方式活化B細胞<br />
C.誘發出來的抗多醣體抗體可降低病菌感染<br />
D.可誘發記憶B細胞的產生</p>
<p>應選B</p>
<p>正確答案: A</p>
<p>為何正確: 肺炎鏈球菌多醣體疫苗並不是多醣體連結蛋白質形成的疫苗，而是純多醣體疫苗。這類疫苗主要以thymus-independent方式活化B細胞，不像蛋白質疫苗可以誘發記憶B細胞的產生。只有連結蛋白質的多醣體疫苗（如結合型疫苗）才能夠誘發記憶B細胞。</p>
<p>選項: A<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-154"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97polysaccharide-vaccine%e4%bb%a5thymus-independent%e6%96%b9%e5%bc%8f%e6%b4%bb%e5%8c%96b%e7%b4%b0%e8%83%9e/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ca0b690900ce5cebea7a4e8973021603</guid>
				<title>MedicsKey.A started the discussion 肺炎鏈球菌多醣體疫苗是以thymus-independent方式活化B細胞，不會誘發記憶B細胞的產生。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97%e6%98%af%e4%bb%a5thymus-independent%e6%96%b9%e5%bc%8f%e6%b4%bb%e5%8c%96b%e7%b4%b0%e8%83%9e%ef%bc%8c%e4%b8%8d/</link>
				<pubDate>Sat, 23 Nov 2024 10:55:24 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97%e6%98%af%e4%bb%a5thymus-independent%e6%96%b9%e5%bc%8f%e6%b4%bb%e5%8c%96b%e7%b4%b0%e8%83%9e%ef%bc%8c%e4%b8%8d/">肺炎鏈球菌多醣體疫苗是以thymus-independent方式活化B細胞，不會誘發記憶B細胞的產生。</a></p> <div class="bb-content-inr-wrap"><p>11322-23 免疫<br />
23.下列有關肺炎鏈球菌多醣體疫苗之敘述，何者最不適當？<br />
A.是多醣體連結蛋白質形成的疫苗<br />
B.以thymus-independent方式活化B細胞<br />
C.誘發出來的抗多醣體抗體可降低病菌感染<br />
D.可誘發記憶B細胞的產生</p>
<p>應選B</p>
<p>正確答案: D.可誘發記憶B細胞的產生</p>
<p>為何正確: 肺炎鏈球菌多醣體疫苗主要是以thymus-independent方式活化B細胞，這類疫苗通常不會誘發記憶B細胞的產生。因此，「可誘發記憶B細胞的產生」這項敘述是不適當的。多醣體疫苗與蛋白質結合后（如在結合型疫苗中），才可能會引發T細胞的參與進而產生記憶B細胞。</p>
<p>選項: A<br />
詳解: 肺炎鏈球菌多醣體疫苗（pneumococcal polysaccharide&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-153"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97%e6%98%af%e4%bb%a5thymus-independent%e6%96%b9%e5%bc%8f%e6%b4%bb%e5%8c%96b%e7%b4%b0%e8%83%9e%ef%bc%8c%e4%b8%8d/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4aefb81e780629822fff9a5357faf4f0</guid>
				<title>MedicsKey.A started the discussion 肺炎鏈球菌多醣體疫苗(Pneumococcal polysaccharide vaccine)不會誘發記憶B細胞的產生。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97pneumococcal-polysaccharide-vaccine%e4%b8%8d%e6%9c%83%e8%aa%98%e7%99%bc%e8%a8%98%e6%86%b6b%e7%b4%b0%e8%83%9e/</link>
				<pubDate>Sat, 23 Nov 2024 10:53:15 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97pneumococcal-polysaccharide-vaccine%e4%b8%8d%e6%9c%83%e8%aa%98%e7%99%bc%e8%a8%98%e6%86%b6b%e7%b4%b0%e8%83%9e/">肺炎鏈球菌多醣體疫苗(Pneumococcal polysaccharide vaccine)不會誘發記憶B細胞的產生。</a></p> <div class="bb-content-inr-wrap"><p>11322-23 免疫<br />
23.下列有關肺炎鏈球菌多醣體疫苗之敘述，何者最不適當？<br />
A.是多醣體連結蛋白質形成的疫苗<br />
B.以thymus-independent方式活化B細胞<br />
C.誘發出來的抗多醣體抗體可降低病菌感染<br />
D.可誘發記憶B細胞的產生</p>
<p>正確答案: A.是多醣體連結蛋白質形成的疫苗</p>
<p>為何正確: 肺炎鏈球菌多醣體疫苗是一種多醣體疫苗，屬於thymus-independent抗原，主要是直接刺激B細胞產生抗體，不是透過將多醣體連結蛋白質來形成的疫苗。因此，它不能有效地誘發T細胞的幫助來產生記憶B細胞。選項 D 提到的「可誘發記憶B細胞的產生」也是關鍵，因為由於缺乏蛋白質載體，此類疫苗不會有效地誘發記憶B細胞。</p>
<p>選項: A<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-152"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%82%ba%e7%82%8e%e9%8f%88%e7%90%83%e8%8f%8c%e5%a4%9a%e9%86%a3%e9%ab%94%e7%96%ab%e8%8b%97pneumococcal-polysaccharide-vaccine%e4%b8%8d%e6%9c%83%e8%aa%98%e7%99%bc%e8%a8%98%e6%86%b6b%e7%b4%b0%e8%83%9e/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b05e0d6526296558530788d10de91b6b</guid>
				<title>MedicsKey.A started the discussion CD40配體（CD40 ligand）與促進B細胞抗體類型轉換的作用相關性最高。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/cd40%e9%85%8d%e9%ab%94%ef%bc%88cd40-ligand%ef%bc%89%e8%88%87%e4%bf%83%e9%80%b2b%e7%b4%b0%e8%83%9e%e6%8a%97%e9%ab%94%e9%a1%9e%e5%9e%8b%e8%bd%89%e6%8f%9b%e7%9a%84%e4%bd%9c%e7%94%a8%e7%9b%b8%e9%97%9c/</link>
				<pubDate>Sat, 23 Nov 2024 09:52:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/cd40%e9%85%8d%e9%ab%94%ef%bc%88cd40-ligand%ef%bc%89%e8%88%87%e4%bf%83%e9%80%b2b%e7%b4%b0%e8%83%9e%e6%8a%97%e9%ab%94%e9%a1%9e%e5%9e%8b%e8%bd%89%e6%8f%9b%e7%9a%84%e4%bd%9c%e7%94%a8%e7%9b%b8%e9%97%9c/">CD40配體（CD40 ligand）與促進B細胞抗體類型轉換的作用相關性最高。</a></p> <div class="bb-content-inr-wrap"><p>11322-22 免疫<br />
22.下列何種CD4效應T細胞（effector CD4 T cells）所分泌的細胞激素（cytokines）或產生的表面分子<br />
（surface molecule）與促進B細胞抗體類型轉換（isotype class switch）的作用相關性最高？<br />
A.IL-2<br />
B.IL-10<br />
C.CD40 ligand<br />
D.CD28</p>
<p>正確答案: C.CD40 ligand</p>
<p>為何正確: CD40配體（CD40 ligand）是CD4效應T細胞（effector CD4 T cells）表面的一種重要分子，與B細胞表面的CD40相互作用，促進B細胞的抗體類型轉換（isotype class switch）。這種相互作用是B細胞有效產生各種類型抗體（例如IgG,&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-151"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/cd40%e9%85%8d%e9%ab%94%ef%bc%88cd40-ligand%ef%bc%89%e8%88%87%e4%bf%83%e9%80%b2b%e7%b4%b0%e8%83%9e%e6%8a%97%e9%ab%94%e9%a1%9e%e5%9e%8b%e8%bd%89%e6%8f%9b%e7%9a%84%e4%bd%9c%e7%94%a8%e7%9b%b8%e9%97%9c/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a090c1d13748e53175b38e3f4ead3d77</guid>
				<title>MedicsKey.A started the discussion 表現IgM的immature B細胞如果辨識到抗原，會經歷負選擇而不是開始細胞分裂（clonal expansion）。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%a1%a8%e7%8f%beigm%e7%9a%84immature-b%e7%b4%b0%e8%83%9e%e5%a6%82%e6%9e%9c%e8%be%a8%e8%ad%98%e5%88%b0%e6%8a%97%e5%8e%9f%ef%bc%8c%e6%9c%83%e7%b6%93%e6%ad%b7%e8%b2%a0%e9%81%b8%e6%93%87%e8%80%8c/</link>
				<pubDate>Sat, 23 Nov 2024 09:38:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%a1%a8%e7%8f%beigm%e7%9a%84immature-b%e7%b4%b0%e8%83%9e%e5%a6%82%e6%9e%9c%e8%be%a8%e8%ad%98%e5%88%b0%e6%8a%97%e5%8e%9f%ef%bc%8c%e6%9c%83%e7%b6%93%e6%ad%b7%e8%b2%a0%e9%81%b8%e6%93%87%e8%80%8c/">表現IgM的immature B細胞如果辨識到抗原，會經歷負選擇而不是開始細胞分裂（clonal expansion）。</a></p> <div class="bb-content-inr-wrap"><p>11322-21 免疫<br />
21.下列關於B細胞發育的敘述，何者最不適當？<br />
A.免疫球蛋白基因的V(D)J重組，先從重鏈（heavy chain）開始<br />
B.μ重鏈（μ heavy chain）與VpreB及λ5組成的pre-BCR，對pre-B細胞繼續發育是必要的<br />
C.Bruton&#8217;s tyrosine kinase（Btk）是pre-BCR或BCR下游訊息傳遞的必要蛋白，缺乏Btk會造成X-linked<br />
 agammaglobulinemia（XLA）<br />
D.表現IgM的immature B細胞如果辨識到抗原，就會開始細胞分裂（clonal&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-150"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%a1%a8%e7%8f%beigm%e7%9a%84immature-b%e7%b4%b0%e8%83%9e%e5%a6%82%e6%9e%9c%e8%be%a8%e8%ad%98%e5%88%b0%e6%8a%97%e5%8e%9f%ef%bc%8c%e6%9c%83%e7%b6%93%e6%ad%b7%e8%b2%a0%e9%81%b8%e6%93%87%e8%80%8c/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0884528153fe06f2fed8bc7b9c7af2d9</guid>
				<title>MedicsKey.A started the discussion T細胞所辨識的抗原，通常為短片段的胜肽（peptide）而非摺疊成複雜的立體結構。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e6%89%80%e8%be%a8%e8%ad%98%e7%9a%84%e6%8a%97%e5%8e%9f%ef%bc%8c%e9%80%9a%e5%b8%b8%e7%82%ba%e7%9f%ad%e7%89%87%e6%ae%b5%e7%9a%84%e8%83%9c%e8%82%bd%ef%bc%88peptide%ef%bc%89%e8%80%8c/</link>
				<pubDate>Sat, 23 Nov 2024 09:31:15 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e6%89%80%e8%be%a8%e8%ad%98%e7%9a%84%e6%8a%97%e5%8e%9f%ef%bc%8c%e9%80%9a%e5%b8%b8%e7%82%ba%e7%9f%ad%e7%89%87%e6%ae%b5%e7%9a%84%e8%83%9c%e8%82%bd%ef%bc%88peptide%ef%bc%89%e8%80%8c/">T細胞所辨識的抗原，通常為短片段的胜肽（peptide）而非摺疊成複雜的立體結構。</a></p> <div class="bb-content-inr-wrap"><p>11322-20&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-149"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9e%e6%89%80%e8%be%a8%e8%ad%98%e7%9a%84%e6%8a%97%e5%8e%9f%ef%bc%8c%e9%80%9a%e5%b8%b8%e7%82%ba%e7%9f%ad%e7%89%87%e6%ae%b5%e7%9a%84%e8%83%9c%e8%82%bd%ef%bc%88peptide%ef%bc%89%e8%80%8c/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ab4d225e17f185eb8578f4ac025c0de9</guid>
				<title>MedicsKey.A started the discussion T細胞(T cell)所辨識的抗原需摺疊成複雜的立體結構，才能被T細胞所辨識是不適當的，因為T細胞主要辨識呈獻在MHC(主要組織相容性複合體，Major Histocompatibility Complex)上的短片段胜肽。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9et-cell%e6%89%80%e8%be%a8%e8%ad%98%e7%9a%84%e6%8a%97%e5%8e%9f%e9%9c%80%e6%91%ba%e7%96%8a%e6%88%90%e8%a4%87%e9%9b%9c%e7%9a%84%e7%ab%8b%e9%ab%94%e7%b5%90%e6%a7%8b%ef%bc%8c%e6%89%8d/</link>
				<pubDate>Sat, 23 Nov 2024 09:25:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9et-cell%e6%89%80%e8%be%a8%e8%ad%98%e7%9a%84%e6%8a%97%e5%8e%9f%e9%9c%80%e6%91%ba%e7%96%8a%e6%88%90%e8%a4%87%e9%9b%9c%e7%9a%84%e7%ab%8b%e9%ab%94%e7%b5%90%e6%a7%8b%ef%bc%8c%e6%89%8d/">T細胞(T cell)所辨識的抗原需摺疊成複雜的立體結構，才能被T細胞所辨識是不適當的，因為T細胞主要辨識呈獻在MHC(主要組織相容性複合體，Major Histocompatibility Complex)上的短片段胜肽。</a></p> <div class="bb-content-inr-wrap"><p>11322-20&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-148"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/t%e7%b4%b0%e8%83%9et-cell%e6%89%80%e8%be%a8%e8%ad%98%e7%9a%84%e6%8a%97%e5%8e%9f%e9%9c%80%e6%91%ba%e7%96%8a%e6%88%90%e8%a4%87%e9%9b%9c%e7%9a%84%e7%ab%8b%e9%ab%94%e7%b5%90%e6%a7%8b%ef%bc%8c%e6%89%8d/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d76d00bd950e561733230b3f815114f7</guid>
				<title>MedicsKey.A started the discussion 補體活化可以由病原菌表面分子啟動，而不僅限於由抗體啟動。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%a3%9c%e9%ab%94%e6%b4%bb%e5%8c%96%e5%8f%af%e4%bb%a5%e7%94%b1%e7%97%85%e5%8e%9f%e8%8f%8c%e8%a1%a8%e9%9d%a2%e5%88%86%e5%ad%90%e5%95%9f%e5%8b%95%ef%bc%8c%e8%80%8c%e4%b8%8d%e5%83%85%e9%99%90%e6%96%bc/</link>
				<pubDate>Sat, 23 Nov 2024 09:20:16 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%a3%9c%e9%ab%94%e6%b4%bb%e5%8c%96%e5%8f%af%e4%bb%a5%e7%94%b1%e7%97%85%e5%8e%9f%e8%8f%8c%e8%a1%a8%e9%9d%a2%e5%88%86%e5%ad%90%e5%95%9f%e5%8b%95%ef%bc%8c%e8%80%8c%e4%b8%8d%e5%83%85%e9%99%90%e6%96%bc/">補體活化可以由病原菌表面分子啟動，而不僅限於由抗體啟動。</a></p> <div class="bb-content-inr-wrap"><p>11322-19 免疫<br />
19.有關補體系統參與先天性免疫防禦之敘述，下列何者最不適當？<br />
A.補體分子C5活化下游C6-C9組成膜攻擊複合體（membrane-attack complex）裂解病原菌<br />
B.補體活化僅能由抗體啟動而非病原菌表面分子<br />
C.活化補體分子可以經由調理作用（opsonization）促進吞噬反應<br />
D.活化補體分子C3a及C5a可以活化肥大細胞（mast cells）促進發炎反應</p>
<p>正確答案: B.補體活化僅能由抗體啟動而非病原菌表面分子</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-147"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e8%a3%9c%e9%ab%94%e6%b4%bb%e5%8c%96%e5%8f%af%e4%bb%a5%e7%94%b1%e7%97%85%e5%8e%9f%e8%8f%8c%e8%a1%a8%e9%9d%a2%e5%88%86%e5%ad%90%e5%95%9f%e5%8b%95%ef%bc%8c%e8%80%8c%e4%b8%8d%e5%83%85%e9%99%90%e6%96%bc/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">cdf3dff6020d12608d62f21cfeae13a9</guid>
				<title>MedicsKey.A started the discussion 缺乏淋巴前驅細胞（common lymphoid progenitor）會嚴重影響後天性免疫系統（adaptive immune system）。 in the forum 免疫學</title>
				<link>https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%bc%ba%e4%b9%8f%e6%b7%8b%e5%b7%b4%e5%89%8d%e9%a9%85%e7%b4%b0%e8%83%9e%ef%bc%88common-lymphoid-progenitor%ef%bc%89%e6%9c%83%e5%9a%b4%e9%87%8d%e5%bd%b1%e9%9f%bf%e5%be%8c%e5%a4%a9%e6%80%a7%e5%85%8d/</link>
				<pubDate>Sat, 23 Nov 2024 09:07:15 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%bc%ba%e4%b9%8f%e6%b7%8b%e5%b7%b4%e5%89%8d%e9%a9%85%e7%b4%b0%e8%83%9e%ef%bc%88common-lymphoid-progenitor%ef%bc%89%e6%9c%83%e5%9a%b4%e9%87%8d%e5%bd%b1%e9%9f%bf%e5%be%8c%e5%a4%a9%e6%80%a7%e5%85%8d/">缺乏淋巴前驅細胞（common lymphoid progenitor）會嚴重影響後天性免疫系統（adaptive immune system）。</a></p> <div class="bb-content-inr-wrap"><p>11322-18 免疫<br />
18.人類的免疫系統由造血幹細胞分化而來，若有一病人缺乏了淋巴前驅細胞（common lymphoid<br />
&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-146"><a href="https://medicskey.com/groups/%e5%85%8d%e7%96%ab%e5%ad%b8/forum/discussion/%e7%bc%ba%e4%b9%8f%e6%b7%8b%e5%b7%b4%e5%89%8d%e9%a9%85%e7%b4%b0%e8%83%9e%ef%bc%88common-lymphoid-progenitor%ef%bc%89%e6%9c%83%e5%9a%b4%e9%87%8d%e5%bd%b1%e9%9f%bf%e5%be%8c%e5%a4%a9%e6%80%a7%e5%85%8d/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>
		